Valued at $13.1 billion by market cap, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) operates as a clinical-stage ...

As a bill prohibiting the use of cell phones in public schools is making its way through the Massachusetts state legislature, ...

One of the newest engineering marvels to come out of Kendall Square will be buried up to 105 feet underground where no one ...

After a proposal to construct separated bike lanes on Broadway drew criticism from residents who feared drastic parking ...

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS ...

Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...

Quotient Therapeutics, a biotech company founded in 2022, hopes to take this transatlantic model and commercialise it. Its main research lab is in Great Chesterford, a village just outside Cambridge, ...

Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...

Founded in Cambridge, Massachusetts in 2010, Moderna was an early pioneer in the development of injectable mRNA-based vaccines and therapies. By mid-2015, Moderna had raised more than $1 billion ...